<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03892889</url>
  </required_header>
  <id_info>
    <org_study_id>031-201-00301</org_study_id>
    <nct_id>NCT03892889</nct_id>
  </id_info>
  <brief_title>A Trial in Adult Subjects With Schizophrenia Treated Prospectively for 6-months With Abilify MyCite®</brief_title>
  <official_title>A Phase IIIb Multi-Center, Open-Label, Mirror-Image, Trial in Adult Subjects With Schizophrenia Treated Prospectively for 6-months With Abilify MyCite®</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Otsuka Pharmaceutical Development &amp; Commercialization, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Otsuka Pharmaceutical Development &amp; Commercialization, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      To compare inpatient psychiatric hospitalization rates while subjects are on oral
      standard-of-care antipsychotic treatment and later switched to Abilify MyCite. This trial
      will include male and female subjects who are 18 to 65 years old and diagnosed with
      schizophrenia. The trial will be conducted at 75 sites in the United States, with the a
      target of enrolling 320 subjects. Subject participation is approximately 8 months, including
      a 45-day screening period, a required 3 months (Months 1 to 3) of Abilify MyCite treatment.
      This will be followed to either a change back to standard-of-care antipsychotic treatment or
      remain on Abilify MyCite for an additional 3 months (Months 4-6). All subjects who complete
      or withdraw from the trial while on Abilify MyCite will receive a telephone call for safety
      follow-up approximately 30 days after their last trial visit.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a phase 3b, open-label, prospective, clinical trial designed to assess the difference
      between inpatient psychiatric hospitalization rates in subjects on oral standard-of-care
      antipsychotic treatment(s) for a period of 6 months followed by a switch to Abilify MyCite
      for a period of 3 months (Months 1 to 3). At the Month 3 visit, the investigator should
      decide if subjects will continue on Abilify MyCite for an additional 3 months (Months 4 to 6)
      or switch to a standard-of-care treatment for the duration of treatment. This trial will
      include male and female subjects who are 18 to 65 years of age, inclusive, with a diagnosis
      of schizophrenia. Subjects must have had at least 1 inpatient psychiatric hospitalization
      within 4 years (48 months) and must have been prescribed oral antipsychotics for at least 6
      months or longer prior to screening. Subjects will enter a screening period (up to 45 days).
      If deemed eligible to participate, subjects will enter an open-label Abilify MyCite treatment
      prospective phase for up to 6 months. All subjects who complete or withdraw from the trial
      while on Abilify MyCite will receive a telephone call for safety follow-up approximately 30
      days after their last trial visit. The trial will be conducted at 75 sites in the United
      States, 493 subjects will be screened in order to enroll 320 subjects and complete 224
      subjects.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 29, 2019</start_date>
  <completion_date type="Anticipated">February 2021</completion_date>
  <primary_completion_date type="Anticipated">October 2020</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Inpatient psychiatric hospitalization</measure>
    <time_frame>3 months</time_frame>
    <description>Comparison of inpatient psychiatric hospitalization rates of subjects on oral standard-of-care antipsychotic treatment and switching to Abilify MyCite.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Improved adherence</measure>
    <time_frame>Retrospective - Months 1-3 and Prospective - Months 1-3</time_frame>
    <description>Improved adherence based on overall proportion of days covered with Abilify MyCite versus retrospective oral atypical antipsychotics.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">320</enrollment>
  <condition>Schizophrenia</condition>
  <arm_group>
    <arm_group_label>ABILIFY MYCITE</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects will receive Abilify MyCite for 3 months (Months 1 to 3) and at the Month 3 visit, the investigator should decide if subjects will continue on Abilify MyCite for an additional 3 months (Months 4 to 6) or switch to a standard-of-care treatment (eg, oral atypical antipsychotics or a long acting injectable [LAI]) for the duration of treatment.</description>
  </arm_group>
  <intervention>
    <intervention_type>Combination Product</intervention_type>
    <intervention_name>ABILIFY MYCITE</intervention_name>
    <description>Abilify MyCite tracks drug ingestion and is composed of an Aripiprazole tablet embedded with a sensor (Abilify MyCite). Abilify MyCite Patch (wearable) detects the signal from the sensor after ingestion and transmits data to a smartphone. Abilify MyCite App, a smartphone app, which is used with a compatible smartphone to display medication ingestion information for the subject. Web-based portal or dashboard for investigators and caregivers.</description>
    <arm_group_label>ABILIFY MYCITE</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subject must be willing and able to give written informed consent, adhere to trial
             procedures and able to read and understand English.

          -  Male and female subjects 18 to 65 years of age

          -  Subject must possess a smartphone and is familiar with its use and is willing to
             download and interact with the Abilify MyCite app. A subject with a smartphone that is
             not compatible with the Abilify MyCite app will be offered a loaner phone for the
             trial period.

          -  Clinical diagnosis of schizophrenia and able to ingest oral medication

          -  Positive and Negative Syndrome Scale (PANSS) total score between 60-90.

          -  Subjects currently prescribed oral atypical antipsychotic medication including
             aripiprazole or appropriate for aripiprazole treatment for 6 months or longer.

          -  Subjects are required to have had an inpatient hospitalization for schizophrenia
             within the last 48 months prior to entering the trial.

          -  Skin on the anterior chest just above the lower edge of the rib cage that is free of
             any dermatological problems

        Exclusion Criteria:

          -  Females who are breast-feeding and/or who are pregnant

          -  Sexually active males or women of childbearing potential (WOCBP) who do not agree to
             practice 2 different methods of birth control or remain abstinent during the trial and
             for 30 days after the last dose of Abilify MyCite.

          -  Any subject who participated in another clinical trial within 30 days of enrollment

          -  Subjects who are currently being treated with an LAI antipsychotic or have been
             treated with an LAI in the retrospective 6-month phase.

          -  Subjects with a current DSM-5 diagnosis other than schizophrenia

          -  Subject with a known allergy to adhesive tape or any pertinent components of the patch
             or aripiprazole tablet embedded with an IEM sensor
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Denise Fox</last_name>
    <phone>617-460-3028</phone>
    <email>denise.fox@quintiles.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Marissa Guzman</last_name>
    <phone>919-998-1878</phone>
    <email>marissa.guzman@quintiles.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Alea Research</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85012</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alyssa McKinney</last_name>
      <phone>602-562-7000</phone>
      <email>amckinney@alearesearchphoenix.com</email>
    </contact>
    <investigator>
      <last_name>Jelena Kunovac</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Woodland International Research Group</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <zip>72211</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Riley Neal</last_name>
      <phone>501-221-8681</phone>
      <email>rneal@ergclinical.com</email>
    </contact>
    <investigator>
      <last_name>Jim Aukstuolis</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>ADVANCED RESEARCH CENTER, Inc.</name>
      <address>
        <city>Anaheim</city>
        <state>California</state>
        <zip>92805</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jeannine Rosete</last_name>
      <phone>714-999-6688</phone>
      <email>jrosete@arctrials.com</email>
    </contact>
    <investigator>
      <last_name>Steven Macina</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CITrials</name>
      <address>
        <city>Bellflower</city>
        <state>California</state>
        <zip>90706</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paige Mansfield</last_name>
      <phone>562-748-4999</phone>
      <email>Paige.Mansfield@citrials.com</email>
    </contact>
    <investigator>
      <last_name>Diane Highum</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Synexus</name>
      <address>
        <city>Cerritos</city>
        <state>California</state>
        <zip>90703</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephen Ingalls</last_name>
      <phone>562-246-3100</phone>
      <email>Stephen.ingalls@synexus-us.com</email>
    </contact>
    <investigator>
      <last_name>Morteza Marandi</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>ProScience Research Group</name>
      <address>
        <city>Culver City</city>
        <state>California</state>
        <zip>90230</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hannah Lark</last_name>
      <phone>424-227-8127</phone>
      <email>hannah.lark@prosciencerg.com</email>
    </contact>
    <investigator>
      <last_name>Marina Bussel</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Collaborative Neuroscience Network, LLC</name>
      <address>
        <city>Garden Grove</city>
        <state>California</state>
        <zip>92845</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>CheRenee Zaragoza</last_name>
      <phone>714-799-7799</phone>
      <email>chereneezaragoza@cnstrial.com</email>
    </contact>
    <investigator>
      <last_name>David Walling</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Behavioral Research Specialists, LLC</name>
      <address>
        <city>Glendale</city>
        <state>California</state>
        <zip>91206</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tristan Biley</last_name>
      <phone>888-255-5798</phone>
      <email>tristan@brstrials.com</email>
    </contact>
    <investigator>
      <last_name>Jesse Carr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>San Fernando Mental Health Center</name>
      <address>
        <city>Granada Hills</city>
        <state>California</state>
        <zip>91344</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Richard Franco</last_name>
      <phone>818-832-6160</phone>
      <email>rfluna@dmh.lacounty.gov</email>
    </contact>
    <investigator>
      <last_name>Alex Kopelowicz</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Synergy San Diego</name>
      <address>
        <city>Lemon Grove</city>
        <state>California</state>
        <zip>91945</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joshua Watts</last_name>
      <phone>619-303-6130</phone>
      <email>wattsj@synergysandiego.com</email>
    </contact>
    <investigator>
      <last_name>Douglas Dolnak</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Pacific Research Partners</name>
      <address>
        <city>Oakland</city>
        <state>California</state>
        <zip>94607</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shawna Cote</last_name>
      <phone>510-444-2877</phone>
      <email>ShawnaCote@pacifictrials.com</email>
    </contact>
    <investigator>
      <last_name>Corinna Gamez</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Excell Research, Inc</name>
      <address>
        <city>Oceanside</city>
        <state>California</state>
        <zip>92056</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joshua Townsend</last_name>
      <phone>760-758-2222</phone>
      <email>Jtownsend@excellresearch.com</email>
    </contact>
    <investigator>
      <last_name>Sherry Soefje</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CNRI-Los Angeles</name>
      <address>
        <city>Pico Rivera</city>
        <state>California</state>
        <zip>90660</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patricia Kaldas</last_name>
      <phone>562-928-8601</phone>
      <email>Patricia.gutierrez@cnrilallc.com</email>
    </contact>
    <investigator>
      <last_name>Raymond Manning</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Prospective Research Innovations Inc.</name>
      <address>
        <city>Rancho Cucamonga</city>
        <state>California</state>
        <zip>91730</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Omar Barnett</last_name>
      <phone>626-414-7902</phone>
      <email>OBarnett@prospectiveinn.com</email>
    </contact>
    <investigator>
      <last_name>Gilbert Martinez</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CITrials</name>
      <address>
        <city>Riverside</city>
        <state>California</state>
        <zip>92506</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Debra Hoffmeyer</last_name>
      <phone>949-338-9258</phone>
      <email>debra@citrials.com</email>
    </contact>
    <investigator>
      <last_name>Dennis Alters</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CNRI-San Diego, LLC</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92102</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robert Perkovic</last_name>
      <phone>619-481-5252</phone>
      <email>Rperkovic.cnri@pacbell.net</email>
    </contact>
    <investigator>
      <last_name>Christopher Benbow</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Artemis Institute for Clinical Research</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92103</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kecia Darbeau</last_name>
      <phone>858-278-3647</phone>
      <email>sdarbeau@artemis-research.com</email>
    </contact>
    <investigator>
      <last_name>Eric Chavez</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CITrials, Inc.</name>
      <address>
        <city>Santa Ana</city>
        <state>California</state>
        <zip>92705</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jonathan Barber</last_name>
      <phone>714-979-4101</phone>
      <email>jonathan.barber@citrials.com</email>
    </contact>
    <investigator>
      <last_name>Evagelos Coskinas</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Siyan Clinical Research</name>
      <address>
        <city>Santa Rosa</city>
        <state>California</state>
        <zip>95401</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amanda Anello</last_name>
      <phone>707-696-8045</phone>
      <email>aanello@siyanclinical.com</email>
    </contact>
    <investigator>
      <last_name>Anish Shah</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Collaborative Neuroscience Network, LLC</name>
      <address>
        <city>Torrance</city>
        <state>California</state>
        <zip>90502</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Deidri Gonzalez</last_name>
      <phone>310-523-4200</phone>
      <email>DeidriGonzalez@cnstrial.com</email>
    </contact>
    <investigator>
      <last_name>Armen Goenjian</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sarkis Clinical Trials</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <zip>32607</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carole Newell</last_name>
      <phone>352-333-0094</phone>
      <email>carole@ehsfamily.com</email>
    </contact>
    <investigator>
      <last_name>Elias Sarkis</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Indago Research &amp; Health Center, Inc.</name>
      <address>
        <city>Hialeah</city>
        <state>Florida</state>
        <zip>33012</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ricardo Vega</last_name>
      <phone>305-825-6588</phone>
      <email>rvega@indagoresearch.org</email>
    </contact>
    <investigator>
      <last_name>Miguel Perez</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>New Life medical Research Inc.</name>
      <address>
        <city>Hialeah</city>
        <state>Florida</state>
        <zip>33012</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Viviana Dobal</last_name>
      <phone>754-360-3750</phone>
      <email>dobal@newlifemedresearch.com</email>
    </contact>
    <investigator>
      <last_name>Lourdes Selem</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Galiz Research</name>
      <address>
        <city>Hialeah</city>
        <state>Florida</state>
        <zip>33016</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Luis Pedraza</last_name>
      <phone>305-805-0921</phone>
      <email>luiusp@galizresearch.com</email>
    </contact>
    <investigator>
      <last_name>Jose Gamez</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Innovative Clinical Research, Inc.</name>
      <address>
        <city>Lauderhill</city>
        <state>Florida</state>
        <zip>33319</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Obrena Wellons</last_name>
      <phone>954-990-6326</phone>
      <email>owellons@segaltrials.com</email>
    </contact>
    <investigator>
      <last_name>Rishi Kakar</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Premier Clinical Research Institute Inc.</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33122</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Juliet Perez</last_name>
      <phone>305-392-0279</phone>
      <email>jperez@pcrinstitute.com</email>
    </contact>
    <investigator>
      <last_name>Emilio Mantero-Atienza</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CCM Clinical Research Group</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33133</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maria Gallagher</last_name>
      <phone>305-285-0705</phone>
      <email>maria@ccmclinicalresearch.com</email>
    </contact>
    <investigator>
      <last_name>Francisco Ricart</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Prestige Clinical Research Center Inc.</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33133</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Naty Diaz</last_name>
      <phone>305-907-6960</phone>
      <email>naty@pcresearchcenter.com</email>
    </contact>
    <investigator>
      <last_name>Patricia Junquera</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Stedman Clinical Tirlas</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33613</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Susan Fowler</last_name>
      <phone>813-971-8311</phone>
      <email>susan_fowler@stedmanclinicaltrials.com</email>
    </contact>
    <investigator>
      <last_name>Mary Stedman</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Nova Psychiatry, Inc</name>
      <address>
        <city>Winter Park</city>
        <state>Florida</state>
        <zip>32789</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carmen Torres</last_name>
      <phone>407-718-3530</phone>
      <email>cjtorre23@gmail.com</email>
    </contact>
    <investigator>
      <last_name>David Medina</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Synexus Clinical Research US</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30328</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bonne Raufman</last_name>
      <phone>404-255-6005</phone>
      <email>Bonnie.Raufman@synexus-us.com</email>
    </contact>
    <investigator>
      <last_name>Bethany Davis</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>David</name>
      <address>
        <city>Decatur</city>
        <state>Georgia</state>
        <zip>30030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Casey Chacona</last_name>
      <phone>404-537-1282</phone>
      <email>casey.chacona@iresearchatlanta.com</email>
    </contact>
    <investigator>
      <last_name>David Purselle</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Uptown Research Institute</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60640</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephen Schneider</last_name>
      <phone>773-989-8313</phone>
      <email>sschneider@uptownresearch.com</email>
    </contact>
    <investigator>
      <last_name>John Sonnenberg</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>AMITA Health</name>
      <address>
        <city>Hoffman Estates</city>
        <state>Illinois</state>
        <zip>60169</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maureen Ganser</last_name>
      <phone>847-230-3992</phone>
      <email>Maureen.ganser@amitahealth.org</email>
    </contact>
    <investigator>
      <last_name>Constantin Abuzatoaie</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Lake Charles Clinical Trial</name>
      <address>
        <city>Lake Charles</city>
        <state>Louisiana</state>
        <zip>70629</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kami Mallett</last_name>
      <phone>337-564-6405</phone>
      <email>kmallett@lcct.us</email>
    </contact>
    <investigator>
      <last_name>Kashinath Yadalam</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Michigan Clinical Research Institute</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48108</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mohammad Al-Matarenh</last_name>
      <phone>734-834-8954</phone>
      <email>m.matarneh78@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Rajaprabhakaran Rajarethinam</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Arch Clinical Trials, LLC</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63118</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bertina Wilson</last_name>
      <phone>314-230-4326</phone>
      <email>bwilson@archclinicaltrials.com</email>
    </contact>
    <investigator>
      <last_name>Junaid Syed</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>PsychCare Consultants Research</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63128</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Syed Zaidi</last_name>
      <phone>314-849-1853</phone>
      <email>Syed.zaidi@pccresearch.org</email>
    </contact>
    <investigator>
      <last_name>Mohd Malik</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Alivation Research, LLC.</name>
      <address>
        <city>Lincoln</city>
        <state>Nebraska</state>
        <zip>68526</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kelly Espenschade</last_name>
      <phone>402-817-2235</phone>
      <email>kespenschade@alivation.com</email>
    </contact>
    <investigator>
      <last_name>Walter Duffy</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Altea Research Institute</name>
      <address>
        <city>Las Vegas</city>
        <state>Nevada</state>
        <zip>89102</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yurie Dean</last_name>
      <phone>702-527-7401</phone>
      <email>ydean@altearesearch.com</email>
    </contact>
    <investigator>
      <last_name>Mustafa Rawaf</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kolade Research Institute/Cal Psychiatric Services</name>
      <address>
        <city>Las Vegas</city>
        <state>Nevada</state>
        <zip>89109</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Monique Myles</last_name>
      <phone>702-910-7213</phone>
      <email>moniquem@calpsychservices.com</email>
    </contact>
    <investigator>
      <last_name>Akindele Kolade</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hassman Research Institute</name>
      <address>
        <city>Berlin</city>
        <state>New Jersey</state>
        <zip>08009</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rudolph McClain</last_name>
      <phone>856-753-7335</phone>
      <email>rmcclain@hritrials.com</email>
    </contact>
    <investigator>
      <last_name>Elan Cohen</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Synexus US</name>
      <address>
        <city>Jamaica</city>
        <state>New York</state>
        <zip>11432</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nancy Cano</last_name>
      <phone>718-969-3005</phone>
      <email>Nancy.Cano@synexus-us.com</email>
    </contact>
    <investigator>
      <last_name>Aggy Vallanat</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Manhattan Behavioral Medicine PLLC</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10036</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anton Storozhenko</last_name>
      <phone>646-678-4073</phone>
      <email>anton@nymbm.com</email>
    </contact>
    <investigator>
      <last_name>Judith Joseph</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Finger Lakes Clinical Research</name>
      <address>
        <city>Rochester</city>
        <state>New York</state>
        <zip>14618</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sarah Northup</last_name>
      <phone>585-241-9670</phone>
      <email>snorthup@flclinical.com</email>
    </contact>
    <investigator>
      <last_name>Sarah Atkinson</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Richmond Behavioral Associates</name>
      <address>
        <city>Staten Island</city>
        <state>New York</state>
        <zip>10312</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jane Gorman</last_name>
      <phone>718-317-5522</phone>
      <email>gorman@rbany.com</email>
    </contact>
    <investigator>
      <last_name>Mark DiBuono</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Midwest Clinical Research Center</name>
      <address>
        <city>Dayton</city>
        <state>Ohio</state>
        <zip>45417</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rebecca Vernon</last_name>
      <phone>937-424-1050</phone>
      <email>rvernon@ergclinical.com</email>
    </contact>
    <investigator>
      <last_name>Otto Dueno</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Signature Research Associates Inc</name>
      <address>
        <city>Fairlawn</city>
        <state>Ohio</state>
        <zip>44333</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carl Faust</last_name>
      <phone>330-835-4000</phone>
      <email>faust.carl@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Anand Chaturvedi</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Charak Clinical research Center</name>
      <address>
        <city>Garfield Heights</city>
        <state>Ohio</state>
        <zip>44125</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Martin Manuel</last_name>
      <phone>216-587-6727</phone>
      <email>mmanuel@charakresearch.com</email>
    </contact>
    <investigator>
      <last_name>Rakesh Ranjan</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Neuro-Behavioral Clinical Research, Inc.</name>
      <address>
        <city>North Canton</city>
        <state>Ohio</state>
        <zip>44720</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Camille Settles</last_name>
      <phone>330-493-1118</phone>
      <email>Csettles@nb-cr.com</email>
    </contact>
    <investigator>
      <last_name>Shishuka Malhotra</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Rivus Wellness &amp; Research Institute</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73112</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Heather Horstkoetter</last_name>
      <phone>405-753-4994</phone>
      <email>heather@rivusinstitute.com</email>
    </contact>
    <investigator>
      <last_name>Marvin Peyton</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cutting Edge Research Group</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73116</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Liz Thompson</last_name>
      <phone>405-603-8068</phone>
      <email>lthompson@cuttingedgeresearch.org</email>
    </contact>
    <investigator>
      <last_name>Willis Holloway</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Suburban Research Associates</name>
      <address>
        <city>Media</city>
        <state>Pennsylvania</state>
        <zip>19063</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mathew Gitlin</last_name>
      <phone>610-891-9024</phone>
      <email>mgitlin@suburbanresearch.com</email>
    </contact>
    <investigator>
      <last_name>Shivkumar Hatti</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Scranton Medical Institute</name>
      <address>
        <city>Scranton</city>
        <state>Pennsylvania</state>
        <zip>18503</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Abraham Gonzales</last_name>
      <phone>570-208-1088</phone>
      <email>agonzales@gminstitutes.com</email>
    </contact>
    <investigator>
      <last_name>Sanjay Chandragiri</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Psychiatric Consultants, PC</name>
      <address>
        <city>Franklin</city>
        <state>Tennessee</state>
        <zip>37067</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jessica Frazer</last_name>
      <phone>615-807-4023</phone>
      <email>jessica@psyconsults.com</email>
    </contact>
    <investigator>
      <last_name>James Hart</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Community Clinical Research, Inc.</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78754</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Isha Bal</last_name>
      <phone>512-597-6715</phone>
      <email>Isha.bal@communityclinical.com</email>
    </contact>
    <investigator>
      <last_name>David Brown</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>InSite Clinical Research</name>
      <address>
        <city>DeSoto</city>
        <state>Texas</state>
        <zip>75115</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kyle West</last_name>
      <phone>972-420-1484</phone>
      <email>kwest@incr.us</email>
    </contact>
    <investigator>
      <last_name>Suresh Sureddi</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Baylor College of Medicine</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Uzma Khalid</last_name>
      <phone>713-873-5145</phone>
      <email>ukhalid@bcm.edu</email>
    </contact>
    <investigator>
      <last_name>Asim Shah</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Pillar Clinical Research</name>
      <address>
        <city>Richardson</city>
        <state>Texas</state>
        <zip>75080</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Iliana Maldonado</last_name>
      <phone>214-396-4844</phone>
      <email>imaldonado@pillarhc.com</email>
    </contact>
    <investigator>
      <last_name>Scott Bartley</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Noetic Psychiatry</name>
      <address>
        <city>Springville</city>
        <state>Utah</state>
        <zip>84663</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Seneca Anderson</last_name>
      <phone>801-369-8989</phone>
      <email>seneca@cedarpsychiatry.com</email>
    </contact>
    <investigator>
      <last_name>Reid Robison</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Northwest Clinical Research Center</name>
      <address>
        <city>Bellevue</city>
        <state>Washington</state>
        <zip>98007</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nidhi Mehta</last_name>
      <phone>425-453-0404</phone>
      <email>nmehta@nwcrc.net</email>
    </contact>
    <investigator>
      <last_name>Shirin Schilling</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>March 21, 2019</study_first_submitted>
  <study_first_submitted_qc>March 26, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 27, 2019</study_first_posted>
  <last_update_submitted>February 25, 2020</last_update_submitted>
  <last_update_submitted_qc>February 25, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 26, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Schizophrenia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aripiprazole</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

